Results 251 to 260 of about 4,419,243 (284)

Right Ventricular Assist Device Therapies

2020
This chapter discusses right ventricular assist device (RVAD) therapies. Current RVAD options include the Impella Right Peripheral, the Tandem Heart, the Protek Duo system, and a surgically placed CentriMag RVAD. Important considerations when choosing a device include operator familiarity, the need for an oxygenator, the availability of a surgeon, and ...
Adrian Alexis-Ruiz, Marisa Cevasco
openaire   +1 more source

Right Ventricular Assist Devices After Heart Transplantation

Transplantation Proceedings, 2020
Severe right ventricular failure (RVF) has a significant incidence among cardiac transplant patients. It is a serious complication and an independent risk factor for postoperative mortality. In this setting, ventricular assist devices (VADs) must be considered if conservative medical management fails. This study sought to examine our series of patients
Sara, Escalona-Rodriguez, Nora, Palomo-López, Ana, Escoresca-Ortega, Alejandro, Adsuar-Gómez, Manuel, Porras-López, Yael, Corcia-Palomo, Rafael, Martin-Bermudez, Luis, Martín-Villén   +7 more
openaire   +2 more sources

Right Ventricular Assistance by Continuous Flow Device

Methods of Information in Medicine, 2007
Summary Objectives·. This work is another step in the development of the circulatory model CARDIOSIM® and of its model library. Continuous flow assistance is often used to support the right ventricular failure. Computer simulation is one of the methods to study the effect of this assistance on the failing ventricle ...
De Lazzari C, Ferrari G
openaire   +2 more sources

Left Ventricular Assist Device in Right Ventricular Failure

The Journal of Heart and Lung Transplantation, 2013
Purpose Left ventricular (LV) assist device (AD) placement for end-stage LV failure (F) is contraindicated with co-existing right ventricular (RV) F. We propose a strategic pre-op management (“HF tune up”) prior to LVAD allowing safe LVAD implant despite RVF. Methods and Materials This single center study identified 47 patients (pts) who underwent
P. Parwani, B.M.P. Gowd, R. Nahar, C. Statz, D. O’Sullivan, N. Chomick, J. Radojevic, J. Gluck, J. Hammond, D. Wencker   +9 more
openaire   +1 more source

Right Ventricular Assist Device Configuration for Remote Decannulation

Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, 2016
Preoperative risk factors, intraoperative fluid shifts, and transfusions place patients at increased risk for right ventricular failure during left ventricular assist device implantation. Despite aggressive use of inotropes and pulmonary vasodilators, in severe cases of RV failure, a right ventricular assist device may be required. For the past several
Vakhtang, Tchantchaleishvili, Fabio, Sagebin, Howard Todd, Massey   +2 more
openaire   +2 more sources

Percutaneous Circulatory Assist Devices for Right Ventricular Failure

Interventional Cardiology Clinics, 2013
Heart failure is a major cause of global morbidity and mortality affecting nearly 24 million individuals worldwide. Although the importance of right ventricular (RV) function has become more apparent over the past few decades, few therapies specifically target RV failure.
Navin K, Kapur, Yousef H, Bader
openaire   +2 more sources

Right Ventricular Failure in Patients with Left Ventricular Assist Devices

Cardiology Clinics, 2012
Right ventricular (RV) failure that develops following LVAD placement is an important and challenging complication that occurs in approximately 15-25% of LVAD patients. Thus, a thorough evaluation that identifies pre-operative clinical predictors of RV failure is crucial to aid in the appropriate treatment and prognostication.
openaire   +2 more sources

Development of an Implantable Small Right Ventricular Assist Device

ASAIO Journal, 2000
Currently, at least two permanent implantable left ventricular assist devices (LVADs) are used clinically. Unfortunately, there is no small implantable right ventricular assist device (RVAD) available, even though at least 25-30% of this patient population has right ventricular failure.
M, Yoshikawa, K, Nakata, T, Takano, T, Maeda, J, Glueck, S, Murabayashi, H, Schima, E, Wolner, Y, Nosé   +8 more
openaire   +2 more sources

Progress in the Development of the DexAide Right Ventricular Assist Device

ASAIO Journal, 2006
The DexAide right ventricular assist device (RVAD) is an implantable centrifugal pump modified from the CorAide left ventricular assist device. As previously published, in vitro performance testing of the DexAide RVAD has met design criteria, and the nominal operating condition of 4 l/min and 20 mm Hg pressure rise was achieved at 2,000 rpm, with a ...
Kiyotaka, Fukamachi, Yoshio, Ootaki, David J, Horvath, Alex L, Massiello, Keiji, Kamohara, Masatoshi, Akiyama, Faruk, Cingoz, Chiyo, Ootaki, Michael W, Kopcak, Raymond, Dessoffy, Jenny, Liu, Ji-Feng, Chen, Qun, Zhou, Stephen, Benefit, Leonard A R, Golding, Sue, Alfini, David T, Rowe   +16 more
openaire   +2 more sources

Ventricular Assist Device Implantation Using a Right Thoracotomy

ASAIO Journal, 2006
Most patients needing implantation of a ventricular assist device (VAD) require repeated sternotomy; some after cardiac surgery, and others later for heart transplantation. The purpose of this study was to establish the right thoracotomy technique as an alternative for VAD implantation to reduce repeated sternotomy-related morbidity and mortality.
Ho Sung, Son, Kyung, Sun, Chang Mo, Hwang, Yong Hu, Fang, Choon Hak, Lim, Hye Won, Lee, Sung Min, Park, Jae Seung, Shin, Kwang Taik, Kim, Hyoung Mook, Kim   +9 more
openaire   +2 more sources